Metastatic adenoid cystic carcinoma of the salivary gland responding to cetuximab plus weekly paclitaxel after no response to weekly paclitaxel alone

  • Caballero M
  • Sosa A
  • Tagliapietra A
 et al. 
  • 19


    Mendeley users who have this article in their library.
  • 11


    Citations of this article.


Adenoid cystic carcinoma (ACC) of the salivary gland frequently develops lung metastases. In cases in which chemotherapy is indicated, resistance is a common phenomenon. New drugs, such as cetuximab, have been chosen to avoid this chemoresistance.

Author-supplied keywords

  • adenoid cystic carcinoma
  • cetuximab
  • chemoresistance
  • metronomic schedule
  • paclitaxel

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document

Get full text


  • Miguel Caballero

  • Aaron E. Sosa

  • Andrea Tagliapietra

  • Juan J. Grau

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free